Thermo Fisher Scientific Inc. (TMO)
NYSE · Healthcare
Thermo Fisher Scientific Inc. Income Statement 2007–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenue | 44.56B | 42.88B | 42.86B | 44.91B | 39.21B | 32.22B | 25.54B | 24.36B | 20.92B | 18.27B | 16.96B | 16.89B | 13.09B | 12.51B | 11.56B | 10.39B | 9.91B | 10.50B | 9.75B |
| Gross Profit | — | — | — | — | — | — | — | — | 11.94B | 10.06B | 9.38B | 8.95B | 6.78B | 6.41B | 5.83B | 5.13B | 4.76B | 5.20B | 4.67B |
| Profitability | |||||||||||||||||||
| Operating Income | 7.75B | 7.34B | 6.86B | 8.39B | 10.03B | 7.79B | 4.59B | 3.78B | 2.96B | 2.46B | 2.34B | 2.50B | 1.61B | 1.48B | 1.25B | 1.19B | 1.00B | 1.23B | 974.4M |
| EBITDA | — | — | — | — | — | — | — | 6.05B | 4.99B | 4.22B | 4.02B | 4.19B | 2.61B | 2.47B | 2.11B | 1.93B | 1.76B | 2.02B | 1.73B |
| Net Income | 6.70B | 6.33B | 6.00B | — | — | — | — | — | — | — | — | — | 1.27B | 1.18B | 1.33B | 1.04B | 850.3M | 980.9M | 748.4M |
| Per Share Data | |||||||||||||||||||
| EPS (diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | $5.59 | $5.09 | $4.92 | $4.71 | $3.48 | $3.21 | $3.46 | $2.53 | $2.01 | $2.25 | $1.69 |
| Shares Outstanding (dil.) | 378M | 383M | 388M | 394M | 397M | 399M | 403M | 406M | 398M | 397M | 402M | 402M | 366M | 367M | 385M | 409M | 423M | 435M | 444M |
Thermo Fisher Scientific Inc. Income Statement — FAQ
Thermo Fisher Scientific Inc. (TMO) income statement over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMO's income statement history?
The chart and table above show Thermo Fisher Scientific Inc.'s income statement by year and by quarter, including the growth rate.